Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech ...

AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market.

To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider ...

Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there's excitement ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

The reintroduction of the "Improving Seniors' Timely Access to Care Act" marks a critical step toward modernizing the prior authorization process within Medicare Advantage plans.

The University of Massachusetts Amherst and healthcare AI company Mendel released a paper this week exploring how often large language models tend to hallucinate when producing medical summaries ...

Adding more concern, the 2022 Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) trial reinforced the FDA’s finding that fibrates did ...

Discussions around healthcare's workforce crisis usually center around providers’ lack of clinicians, but there’s a sweeping shortage of revenue cycle workers, too. In a new report, Experian ...

After widespread AI experimentation in 2024, companies will face pressure to show real returns on their AI investments in 2025. This will drive adoption of vertical AI solutions that are purpose ...

Healthcare technology news, life science current events. Why This Former OpenAI Exec Is Urging Health Leaders to ‘Specialize in Empathy’ ...

Verdiva Bio’s once-a-week oral GLP-1 drug is ready for Phase 2 testing. The drug, made with a proprietary technology that enables oral dosing, was licensed from Sciwind Biosciences.